206 related articles for article (PubMed ID: 22139839)
1. miR-125b and miR-155 contribute to BCL2 repression and proliferation in response to CD40 ligand (CD154) in human leukemic B-cells.
Willimott S; Wagner SD
J Biol Chem; 2012 Jan; 287(4):2608-17. PubMed ID: 22139839
[TBL] [Abstract][Full Text] [Related]
2. miR-15 and miR-16 induce apoptosis by targeting BCL2.
Cimmino A; Calin GA; Fabbri M; Iorio MV; Ferracin M; Shimizu M; Wojcik SE; Aqeilan RI; Zupo S; Dono M; Rassenti L; Alder H; Volinia S; Liu CG; Kipps TJ; Negrini M; Croce CM
Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13944-9. PubMed ID: 16166262
[TBL] [Abstract][Full Text] [Related]
3. Transformer 2β and miR-204 regulate apoptosis through competitive binding to 3' UTR of BCL2 mRNA.
Kuwano Y; Nishida K; Kajita K; Satake Y; Akaike Y; Fujita K; Kano S; Masuda K; Rokutan K
Cell Death Differ; 2015 May; 22(5):815-25. PubMed ID: 25342468
[TBL] [Abstract][Full Text] [Related]
4. Stromal cells and CD40 ligand (CD154) alter the miRNome and induce miRNA clusters including, miR-125b/miR-99a/let-7c and miR-17-92 in chronic lymphocytic leukaemia.
Willimott S; Wagner SD
Leukemia; 2012 May; 26(5):1113-6. PubMed ID: 22024720
[No Abstract] [Full Text] [Related]
5. CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia.
Willimott S; Baou M; Naresh K; Wagner SD
Br J Haematol; 2007 Sep; 138(6):721-32. PubMed ID: 17760804
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression.
Zhao A; Zeng Q; Xie X; Zhou J; Yue W; Li Y; Pei X
J Genet Genomics; 2012 Jan; 39(1):29-35. PubMed ID: 22293115
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
Sun C; Liu Z; Li S; Yang C; Xue R; Xi Y; Wang L; Wang S; He Q; Huang J; Xie S; Jiang W; Li D
Oncotarget; 2015 Sep; 6(28):25533-74. PubMed ID: 26325180
[TBL] [Abstract][Full Text] [Related]
8. Role of microRNA-182 in posterior uveal melanoma: regulation of tumor development through MITF, BCL2 and cyclin D2.
Yan D; Dong XD; Chen X; Yao S; Wang L; Wang J; Wang C; Hu DN; Qu J; Tu L
PLoS One; 2012; 7(7):e40967. PubMed ID: 22848417
[TBL] [Abstract][Full Text] [Related]
9. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.
Pallasch CP; Patz M; Park YJ; Hagist S; Eggle D; Claus R; Debey-Pascher S; Schulz A; Frenzel LP; Claasen J; Kutsch N; Krause G; Mayr C; Rosenwald A; Plass C; Schultze JL; Hallek M; Wendtner CM
Blood; 2009 Oct; 114(15):3255-64. PubMed ID: 19692702
[TBL] [Abstract][Full Text] [Related]
10. MiR-182-5p regulates BCL2L12 and BCL2 expression in acute myeloid leukemia as a potential therapeutic target.
Zhang S; Zhang Q; Shi G; Yin J
Biomed Pharmacother; 2018 Jan; 97():1189-1194. PubMed ID: 29136958
[TBL] [Abstract][Full Text] [Related]
11. Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway.
Lapalombella R; Andritsos L; Liu Q; May SE; Browning R; Pham LV; Blum KA; Blum W; Ramanunni A; Raymond CA; Smith LL; Lehman A; Mo X; Jarjoura D; Chen CS; Ford R; Rader C; Muthusamy N; Johnson AJ; Byrd JC
Blood; 2010 Apr; 115(13):2619-29. PubMed ID: 19965642
[TBL] [Abstract][Full Text] [Related]
12. Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia.
Lin K; Farahani M; Yang Y; Johnson GG; Oates M; Atherton M; Douglas A; Kalakonda N; Pettitt AR
Br J Haematol; 2014 Nov; 167(3):346-55. PubMed ID: 25040181
[TBL] [Abstract][Full Text] [Related]
13. miR-1266-5p and miR-185-5p Promote Cell Apoptosis in Human Prostate Cancer Cell Lines.
Ostadrahimi S; Abedi Valugerdi M; Hassan M; Haddad G; Fayaz S; Parvizhamidi M; Mahdian R; Fard Esfahani P
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2305-2311. PubMed ID: 30141307
[TBL] [Abstract][Full Text] [Related]
14. Role of miR-15/16 in CLL.
Pekarsky Y; Croce CM
Cell Death Differ; 2015 Jan; 22(1):6-11. PubMed ID: 24971479
[TBL] [Abstract][Full Text] [Related]
15. miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2.
Yadav S; Pandey A; Shukla A; Talwelkar SS; Kumar A; Pant AB; Parmar D
J Biol Chem; 2011 Oct; 286(43):37347-57. PubMed ID: 21878650
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2.
Shang C; Lu YM; Meng LR
Med Sci Monit; 2012 Apr; 18(4):BR149-55. PubMed ID: 22460089
[TBL] [Abstract][Full Text] [Related]
17. Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemia.
Lee TY; Ezelle HJ; Venkataraman T; Lapidus RG; Scheibner KA; Hassel BA
J Interferon Cytokine Res; 2013 Jan; 33(1):34-42. PubMed ID: 23113544
[TBL] [Abstract][Full Text] [Related]
18. miR-202 Suppresses Hepatocellular Carcinoma Progression via Downregulating BCL2 Expression.
Zhuang D; Liang L; Zhang H; Feng X
Oncol Res; 2020 Sep; 28(4):399-408. PubMed ID: 32272979
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells.
Lin YC; Lin JF; Tsai TF; Chou KY; Chen HE; Hwang TI
Asian J Surg; 2017 Sep; 40(5):396-406. PubMed ID: 27519795
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA regulates human vitamin D receptor.
Mohri T; Nakajima M; Takagi S; Komagata S; Yokoi T
Int J Cancer; 2009 Sep; 125(6):1328-33. PubMed ID: 19437538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
